Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Richman

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Immunological Investigations|June 1, 1986
Monoclonal antibodies to acetylcholine receptor secreted by human x human hybridomas derived from lymphocytes of a patient with myasthenia gravisD A Blair, D P Richman, C J Taves, et al.
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1990
Noninflammatory immune mechanisms in diseases of the nervous systemD P Richman, R H Fairclough, Q Xu, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin bindingQ Xu, G M Twaddle, D P Richman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunityM Mihovilovic, D Donnelly-Roberts, D P Richman, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravisC A Kirvan, S Zhu, D P Richman, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravisK Stefansson, M E Dieperink, D P Richman, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodiesR A Maselli, B Jow, D P Richman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membraneA L Corey, D P Richman, M A Agius, et al.
Annals of the New York Academy of Sciences|June 21, 1993
An immunogenic self-peptide for T cells in mice with experimental myastheniaQ Xu, M Agius, E Gudipati, et al.
Muscle & Nerve|December 1, 1991
Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studiesR A Maselli, D P Mass, B J Distad, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Immunological Investigations|June 1, 1986
Monoclonal antibodies to acetylcholine receptor secreted by human x human hybridomas derived from lymphocytes of a patient with myasthenia gravisD A Blair, D P Richman, C J Taves, et al.
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1990
Noninflammatory immune mechanisms in diseases of the nervous systemD P Richman, R H Fairclough, Q Xu, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin bindingQ Xu, G M Twaddle, D P Richman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunityM Mihovilovic, D Donnelly-Roberts, D P Richman, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravisC A Kirvan, S Zhu, D P Richman, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravisK Stefansson, M E Dieperink, D P Richman, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodiesR A Maselli, B Jow, D P Richman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membraneA L Corey, D P Richman, M A Agius, et al.
Annals of the New York Academy of Sciences|June 21, 1993
An immunogenic self-peptide for T cells in mice with experimental myastheniaQ Xu, M Agius, E Gudipati, et al.
Muscle & Nerve|December 1, 1991
Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studiesR A Maselli, D P Mass, B J Distad, et al.
Pageof 8